Lantheus Holdings Share Price Today: Live Updates & Key Insights
Lantheus Holdings share price today is $76.17, up -2%. The stock opened at $77.95 against the previous close of $77.99, with an intraday high of $77.95 and low of $75.63.
Lantheus Holdings Share Price Chart
Lantheus Holdings
Lantheus Holdings Share Price Performance
Lantheus Holdings Institutional Holdings
Lantheus Holdings Market Status
Lantheus Holdings Fundamentals
Market Cap 5068.21 M
PB Ratio 4.531
PE Ratio 22.4135
Enterprise Value 5198.14 M
Total Assets 2227.40 M
Volume 1890429
Lantheus Holdings Company Financials
About Lantheus Holdings & investment objective
Company Information Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. It also provides Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; PYLARIFY AI, an medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer; and flurpiridaz used to assess blood flow to the heart. In addition, it develops PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy to patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent for Tau tangles in Alzheimer's disease; LNTH-2401, a novel radiodiagnostic targeting the gastrin-releasing peptide receptor; LNTH-2402; LNTH-2403; LNTH-2404; LNTH-250; LNTH-2515; and LNTH-1363S, an fibroblast activation protein, alpha, copper-64 labeled PET imaging agent. It has collaboration agreements with GE Healthcare; Curium Pharma; POINT; Regeneron; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.
Organisation Drug Manufacturers - Specialty & Generic
Employees 1193
Industry Drug Manufacturers - Specialty & Generic
CEO Ms. Mary Anne Heino
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Lantheus Holdings FAQs
What is the share price of Lantheus Holdings today?
The current share price of Lantheus Holdings is $76.17.
Can I buy Lantheus Holdings shares in India?
Yes, Indian investors can buy Lantheus Holdings shares by opening an international trading and demat account with Motilal Oswal.
How to buy Lantheus Holdings shares in India?
You can easily invest in Lantheus Holdings shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Lantheus Holdings shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Lantheus Holdings.
Can I buy fractional shares of Lantheus Holdings?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Lantheus Holdings?
Lantheus Holdings has a market cap of $5068.21 M.
In which sector does Lantheus Holdings belong?
Lantheus Holdings operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in Lantheus Holdings stocks?
To invest, you typically need:
What is the PE and PB ratio of Lantheus Holdings?
The PE ratio of Lantheus Holdings is 22.41 and the PB ratio is 4.53.